<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 1.4: Prediabetes and Metabolic Syndrome: The Silent Epidemic</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Diabetes/Blood Sugar */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f0f7ff 0%, #e0f2fe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bae6fd;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
            text-align: center;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
            text-align: center;
        }

        /* Table Styles */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        .data-table th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        .data-table td {
            padding: 14px 15px;
            border-bottom: 1px solid #f1f5f9;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border: 1px solid #eee;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
        }

        .references-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-list li {
            margin-bottom: 10px;
            color: #666;
            line-height: 1.5;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 1: The Foundations of Glycemic Regulation</p>
            <h1 class="lesson-title">Lesson 1.4: Prediabetes and Metabolic Syndrome: The Silent Epidemic</h1>
            <div class="lesson-meta">
                <span class="meta-item">30 min read</span>
                <span class="meta-item">Lesson 4 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Defining the Spectrum</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Metabolic Syndrome Criteria</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Hyperinsulinemia Engine</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Advanced Clinical Biomarkers</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Silent Epidemic Data</a></li>
                <li><a href="#section6"><span class="section-num">6</span>STABLE Methodâ„¢ Reversal</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between clinical prediabetes and the broader definition of metabolic syndrome.</li>
                <li>Identify the five diagnostic criteria for Metabolic Syndrome (MetS) according to ATP III guidelines.</li>
                <li>Analyze why "normal" A1c levels can mask underlying hyperinsulinemia and metabolic dysfunction.</li>
                <li>Calculate and interpret the HOMA-IR score for assessing insulin resistance.</li>
                <li>Apply the STABLE Methodâ„¢ framework to early-stage metabolic stabilization.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Warning Before the Storm</h3>
            <p>Prediabetes is often framed as a "lite" version of Type 2 Diabetesâ€”a minor elevation in blood sugar that requires "watching." This is a dangerous clinical misconception. In the AccrediPro methodology, we view prediabetes and Metabolic Syndrome not as a waiting room for disease, but as <span class="highlight">active metabolic failure</span> already causing systemic damage. By the time the blood sugar rises into the prediabetic range, the underlying pathology of insulin resistance has often been progressing for a decade or more.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Metabolic Syndrome (MetS)</p>
                    <p class="definition">A cluster of conditionsâ€”increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levelsâ€”that occur together, increasing risk of heart disease, stroke, and type 2 diabetes.</p>
                </div>
                <div class="term-item">
                    <p class="term">HOMA-IR</p>
                    <p class="definition">Homeostatic Model Assessment for Insulin Resistance. A calculation using fasting insulin and fasting glucose to determine how hard the pancreas is working.</p>
                </div>
                <div class="term-item">
                    <p class="term">Visceral Adiposity</p>
                    <p class="definition">Fat stored deep within the abdominal cavity, surrounding internal organs; metabolically active and highly inflammatory.</p>
                </div>
                <div class="term-item">
                    <p class="term">Acanthosis Nigricans</p>
                    <p class="definition">Dark, velvety patches of skin in body folds (neck, armpits), a classic physical sign of high circulating insulin.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">Defining the Spectrum of Dysglycemia</h2>
        <p>Blood sugar regulation exists on a continuum. On one end, we have metabolic flexibilityâ€”the ability to switch between fuel sources seamlessly. On the other, we have overt Type 2 Diabetes. Prediabetes sits in the middle, defined by the American Diabetes Association (ADA) as an <span class="highlight">A1c between 5.7% and 6.4%</span> or a fasting plasma glucose of 100â€“125 mg/dL.</p>
        
        <p>However, the <span class="highlight">STABLE Methodâ„¢</span> teaches us that these thresholds are arbitrary. A client with an A1c of 5.6% who has a high waist-to-hip ratio and elevated triglycerides is clinically "normal" by ADA standards but metabolically identical to a prediabetic. This is why we must look at the "Syndrome" rather than just the "Sugar."</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">98M</div>
                    <div class="stat-label">US Adults with Prediabetes</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">81%</div>
                    <div class="stat-label">Don't Know They Have It</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">5x</div>
                    <div class="stat-label">Increased Risk of T2D</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2x</div>
                    <div class="stat-label">Increased Risk of CVD</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Metabolic Syndrome: The Cluster of Risk</h2>
        <p>Metabolic Syndrome (MetS) is a more comprehensive diagnostic tool than prediabetes alone. According to the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III), a diagnosis is made when a client meets <span class="highlight">at least three</span> of the following five criteria:</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Risk Factor</th>
                        <th>Defining Level</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Abdominal Obesity</strong></td>
                        <td>Waist >40 in (Men) / >35 in (Women)</td>
                        <td>Indicates high visceral fat and portal vein inflammation.</td>
                    </tr>
                    <tr>
                        <td><strong>Triglycerides</strong></td>
                        <td>â‰¥ 150 mg/dL</td>
                        <td>Marker of carbohydrate intolerance and liver fat.</td>
                    </tr>
                    <tr>
                        <td><strong>HDL Cholesterol</strong></td>
                        <td>< 40 mg/dL (Men) / < 50 mg/dL (Women)</td>
                        <td>Low "protective" cholesterol often paired with high TG.</td>
                    </tr>
                    <tr>
                        <td><strong>Blood Pressure</strong></td>
                        <td>â‰¥ 130/85 mmHg</td>
                        <td>Insulin causes sodium retention and vascular stiffness.</td>
                    </tr>
                    <tr>
                        <td><strong>Fasting Glucose</strong></td>
                        <td>â‰¥ 100 mg/dL</td>
                        <td>The "late stage" marker of hepatic insulin resistance.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">The Hyperinsulinemia Engine</h2>
        <p>The core driver of both prediabetes and MetS is <span class="highlight">Hyperinsulinemia</span>. Long before blood sugar rises, the body compensates for insulin resistance by pumping out massive amounts of insulin. This is known as the "compensatory phase."</p>
        
        <p>A client can maintain a "perfect" fasting glucose of 85 mg/dL, but if it takes 30 Î¼U/mL of insulin to keep it there (normal is < 5 Î¼U/mL), they are in a state of metabolic crisis. High insulin is pro-inflammatory, pro-growth (leading to skin tags and weight gain), and prevents the body from accessing stored body fat for fuel.</p>

        <div class="alert-box warning">
            <p class="alert-label">Practitioner Insight</p>
            <p>Do not rely solely on A1c. A1c is a 3-month average that can be skewed by red blood cell lifespan. A "normal" A1c of 5.2% can coexist with severe metabolic syndrome if the client has significant glycemic variability (high spikes followed by deep crashes).</p>
        </div>

        <h2 id="section4">Advanced Clinical Biomarkers</h2>
        <p>To provide premium coaching, you must understand the data that standard physicals often miss. Under the <strong>Tactical Tracking (T)</strong> pillar of the STABLE Methodâ„¢, we look at the following:</p>

        <p><strong>1. HOMA-IR (Homeostatic Model Assessment):</strong><br>
        Formula: (Fasting Insulin [Î¼U/mL] Ã— Fasting Glucose [mg/dL]) / 405.<br>
        <em>Interpretation:</em> < 1.0 is optimal; > 1.9 indicates early insulin resistance; > 2.9 indicates significant insulin resistance.</p>

        <p><strong>2. Triglyceride-to-HDL Ratio:</strong><br>
        <em>Interpretation:</em> A ratio > 3.0 is a strong surrogate marker for insulin resistance and the presence of small, dense LDL particles. Ideally, this ratio should be < 1.5.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Fit" Prediabetic</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Identifying Hidden Metabolic Failure</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Mark, 44, Executive</h4>
                        <p>Symptoms: Afternoon fatigue, "stubborn" belly fat, skin tags on neck.</p>
                    </div>
                </div>
                <p><strong>Initial Labs:</strong> A1c 5.5% (Normal), Fasting Glucose 94 mg/dL (Normal), BP 132/88 (Borderline).</p>
                <p><strong>AccrediPro Analysis:</strong> We requested a Fasting Insulin test. Mark's insulin was 22 Î¼U/mL. His HOMA-IR was calculated at 5.1 (Severe Insulin Resistance). Despite his "normal" blood sugar, his pancreas was working 5x harder than it should.</p>
                <p><strong>Intervention:</strong> Applied the <strong>S (Stabilization)</strong> and <strong>E (Evolutionary Nutrition)</strong> pillars. Reduced refined carbohydrate frequency and implemented a 14:10 fasting window.</p>
                <p><strong>Outcome:</strong> In 12 weeks, Fasting Insulin dropped to 8 Î¼U/mL, skin tags resolved, and Mark lost 14 lbs of visceral fat without a change in total calorie intake.</p>
            </div>
        </div>

        <h2 id="section5">The Silent Epidemic Data</h2>
        <p>A 2021 study published in <em>JAMA</em> found that the prevalence of metabolic syndrome in the US adult population is approximately <span class="highlight">34.7%</span>. Even more staggering is that for adults over age 60, this number rises to nearly 50%. This is an epidemic of "Metabolic Dysflexibility," where the body has lost the ability to efficiently switch between burning sugar and burning fat.</p>

        <div class="alert-box info">
            <p class="alert-label">The Dawn Phenomenon Connection</p>
            <p>In prediabetes, the liver often becomes insulin resistant first. This leads to excessive glucose production overnight (gluconeogenesis), causing high "fasting" morning numbers even if the client ate no carbs the night before. This is a key teaching point for your clients.</p>
        </div>

        <h2 id="section6">STABLE Methodâ„¢ Reversal Strategies</h2>
        <p>Reversing prediabetes and MetS requires more than "eating less." We use the <strong>STABLE Methodâ„¢</strong> to address the root causes:</p>

        <div class="key-terms-box">
            <p class="box-label">Applying the STABLE Framework</p>
            <ul style="list-style:none; padding:0;">
                <li style="margin-bottom:15px;"><strong>S (Stabilization):</strong> Flatten the postprandial curve. We use fiber-first eating patterns to slow glucose absorption.</li>
                <li style="margin-bottom:15px;"><strong>T (Tactical Tracking):</strong> Use CGMs to identify "silent" spikes from stress or specific "healthy" foods like oatmeal or grapes that may be triggers for that individual.</li>
                <li style="margin-bottom:15px;"><strong>A (Active Sensitization):</strong> 10-minute walks after meals to activate GLUT4 receptors, clearing glucose without requiring more insulin.</li>
                <li style="margin-bottom:15px;"><strong>L (Lifestyle):</strong> Prioritizing sleep. One night of 4-hour sleep can increase insulin resistance by up to 25% the following day.</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of prediabetes and MetS diagnosis.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client presents with a waist circumference of 38 inches (female), triglycerides of 160 mg/dL, and a fasting glucose of 95 mg/dL. Does she meet the criteria for Metabolic Syndrome?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Yes. She meets 3 criteria: 1) Abdominal obesity (>35" for women), 2) Elevated triglycerides (â‰¥150 mg/dL), and 3) Though her glucose is <100, the ATP III criteria only requires 3 out of 5. However, she also has elevated TG and Waist, making her high risk. <i>Waitâ€”correction:</i> She only meets TWO (Waist and TG). She would need one more (BP, HDL, or Glucose) for a clinical diagnosis. This highlights the importance of checking all five markers!
                </div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why is fasting insulin a more sensitive marker for early metabolic dysfunction than fasting glucose?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Because the body will prioritize maintaining stable blood glucose at all costs. It will over-produce insulin for years to keep glucose in the "normal" range. Glucose only rises once the pancreas can no longer keep up with the demand or the cells become too resistant.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Prediabetes is defined by an A1c of 5.7â€“6.4%, but metabolic damage begins much earlier.</li>
                <li>Metabolic Syndrome requires 3 of 5 criteria: Waist size, Triglycerides, HDL, BP, and Fasting Glucose.</li>
                <li>Hyperinsulinemia is the hidden driver that precedes hyperglycemia by a decade.</li>
                <li>HOMA-IR is the "gold standard" coaching metric for assessing insulin resistance severity.</li>
                <li>Reversal is possible through the STABLE Methodâ„¢ by focusing on insulin sensitivity rather than just calorie restriction.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Hirode, G. et al. (2020). "Trends in Prevalence of Metabolic Syndrome in the United States, 2011-2016." <i>JAMA</i>.</li>
                <li>Grundy, S. M. et al. (2005). "Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement." <i>Circulation</i>.</li>
                <li>DeFronzo, R. A. et al. (2015). "Type 2 diabetes mellitus." <i>Nature Reviews Disease Primers</i>.</li>
                <li>CDC. (2023). "National Diabetes Statistics Report." <i>Centers for Disease Control and Prevention</i>.</li>
                <li>Kraft, J. R. (2008). "Detection of Diabetes Mellitus in Situ (Occult Diabetes)." <i>Laboratory Medicine</i>.</li>
                <li>Matthews, D. R. et al. (1985). "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man." <i>Diabetologia</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>